SUMMARY
It has become increasingly clear that only antibodies recognizing conformationdependent epitopes of myelin oligodendrocyte glycoprotein (MOG) have a demyelinating potential in the animal model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE). Nevertheless, for the induction of EAE, most studies to date have used MOG peptides or bacterially expressed MOG, neither of which containing the tertiary structure of the native antigen. Non-refolded recombinant human MOG does not induce EAE in DA rats. Therefore, we refolded this protein in order to assess the influence of MOG conformation on its pathogenicity in DA rats. DA rats immunized with refolded human MOG developed severe acute EAE. As expected, rats immunized with the refolded protein had a higher amount of conformational MOG antibodies present in serum. But in addition, a striking effect of MOG refolding on the generation of T-cell responses was found. Indeed, T-cell responses against the encephalitogenic MOG 91-108 epitope were greatly enhanced after refolding.
Therefore we conclude that refolding of MOG increases its pathogenicity both by generating conformation-dependent MOG antibodies and by enhancing its processing or/and presentation on MHC molecules. This data is important in regard to investigations of the pathogenic potential of many (auto)antigens.
Multiple scleroris (MS) is a chronic demyelinating disease of the CNS. It is supposedly caused by an autoaggressive attack of T-and B-cells against components of the CNS (1) . Identifying the targets of this autoimmune attack has been the topic of numerous studies. Recently we have eluted naturally presented peptides from the CNS of patients with MS (2) . Whereas T-cell responses against several different myelin antigens have been implicated in disease pathogenesis, research on pathogenic humoral responses has mainly focussed on myelin oligodendrocyte glycoprotein (MOG) ever since it was shown that antibodies against MOG can induce demyelination (3) (4) (5) . MOG is a minor CNSspecific myelin protein, but due to its localization at the outermost surface of the myelin sheath, it is accessible for antibodies (6) . It is becoming increasingly clear though, that not all MOG antibodies are pathogenic: only antibodies recognizing conformational MOG epitopes are capable of inducing demyelination (7, 8) . This might partially explain the Protein conformation determines encephalitogenicity controversy which exists around the contribution of MOG-antibodies to MS pathology since several studies used methods for measuring anti-MOG responses failing to discriminate between antibodies recognizing conformational and linear epitopes (9, 10) . Unfortunately, more recent reports using conformation-sensitive methods for determination of MOG antibodies in MS patients still do not offer a consensus on the matter as cell-based assays detected significant amounts of MOG antibodies in certain subsets of MS patients (11) (12) (13) , whereas liquid phase assays failed to do so (14) (15) (16) . Taken together, the pathogenic role of MOGantibodies in humans is still controversial and awaits further clarification. In addition, antibodies against different MOG variants have not been investigated up to date in a systematic way (17) .
MOG-induced EAE mimics several aspects of MS such as demyelination and axonal loss (18) (19) (20) . Disease is routinely induced in rats or mice by immunization with MOG peptides or with the bacterially expressed extracellular part of MOG (MOG 1-125). Studies with B-cell deficient mice have clearly demonstrated that Bcells are not critical for the development of MOG-peptide induced disease (21) . Still, even the pathological significance of MOG-antibodies in models of experimental autoimmune encephalomyelitis (EAE) induced with MOG protein is not completely clarified (22, 23) . Thus it was shown that induction of EAE in C57BL/6 mice with recombinant MOG 1-125 from human origin but not from rat origin is B-cell dependent although both immunization protocols lead to the generation of comparable titers of anti-MOG antibodies (24, 25) .
It is important to keep in mind though that bacterial overexpression of MOG 1-125 usually leads to the expression of the protein under the form of inclusion bodies. Provided an efficient protein refolding protocol is applied, the resulting protein does not have its native conformation and lacks the correct disulfide bond which is present in the extracellular part of the molecule. Currently, the most common way of preparing extracellular MOG, is to purify a His-tagged form of the protein from Escherichia coli by metal-chromatography under denaturing conditions. Subsequent dialysis of purified MOG against phosphate buffered saline (PBS) yields a partially precipitated preparation, whereas dialysis against an acidic acetate buffer yields a soluble form of the protein. Both preparations, lacking the native conformation, have been shown to induce EAE in susceptible strains of rats and mice, although the soluble form of the protein is generally considered more pathogenic (18, 26, 27) .
We used correctly refolded recombinant human MOG (rHuMOG) to induce disease in DA rats and compared its effect on pathogenicity, B-cell and T-cell responses relative to precipitated and soluble rHuMOG. Based on the current concepts about MOG conformation, we expected refolded rHuMOG to be more pathogenic than its non-refolded counterparts due to the presence of conformational MOG antibodies. As expected, refolded rHuMOG was extremely pathogenic in DA rats and this correlated with the presence of conformational MOG antibodies in the serum of DA rats. Still, the strong pathogenicity of refolded rHuMOG could not solely be attributed to the presence of conformational MOG antibodies. Indeed, we equally found a strong contribution of MOG conformation on MOGdirected T-cell responses.
EXPERIMENTAL PROCEDURES
Animals-Female DA rats were obtained from Harlan Winkelmann (Borchen, Germany). Rats were kept under specific pathogen-free (SPF) conditions and obtained food and water ad libitum.
rHuMOG preparations-The cDNA sequence encoding the extracellular domain (MOG 1-125) of the mature HuMOG protein was subcloned into the pQE60 vector (Qiagen, Hilden, Germany). The protein was overexpressed in inclusion bodies in Escherichia coli. The resulting C-terminal His-tagged fusion protein was purified by metal chelate affinity chromatography on Ni-NTA agarose (Qiagen). Non-refolded rHuMOG was obtained by performing Ni-NTA chromatography under denaturing conditions in the presence of 8 M urea. Subsequently, the purified protein was dialyzed extensively against PBS, which lead to the formation of a precipitated rHuMOG preparation (rHuMOG PBS ) or against 10 mM sodium acetate pH3, which lead to the formation of a soluble, non-refolded form of the protein (rHuMOG AC ).
Refolded rHuMOG (rHuMOG REF ) was obtained by including a refolding step while the protein was bound to the Ni-NTA column, as described elsewhere (28) and was completely soluble in PBS. Purity of the obtained rHuMOG preparations was verified by SDS-PAGE. The extracellular part of rRMOG was purified as previously described (18) Negative controls were performed by omitting the primary antibody or applying nonimmune sera or isotype control antibodies. Inflammatory lesions were quantified by couting inflmmatory infiltrates in HE stained spinal cord sections on overview photographs (x40). The inflammatory index was evaluated as follows: the mean number of perivascular inflammatory infiltrates from an average of 15 complete crosssections of the spinal cord of an animal. ELISPOT-Nitrocellulose-bottomed 96-well plates (MAHA; Millipore, Molsheim, France) were coated with an anti-interferon-γ (anti-IFN-γ) mouse monoclonal antibody (mAb) DB1 (a generous gift from Peter van der Meide, TNO, Primate Center, Rijswijk, The Netherlands). Following washing with PBS, plates were blocked with CM (Life Technologies). MNCs (4.10 5 per well) in 200 µl CM containing 50 µM 2-ME and antigen were added to the plates and incubated for 48 hours at 37°C in a humidified atmosphere containing 5% CO 2 . For each antigen, duplicate determinations were performed. rHuMOG preparations and rRMOG were used at a concentration of 5 µg/ ml, peptides at a concentration of 10 µg/ ml and Concanavalin A (Sigma) at a concentration of 1 µg/ ml. Cells were discarded, and plates were washed 4 times with PBS. Secreted IFN-γ was visualized with biotinylated DB12, a mAb against rat IFN-γ (Peter van der Meide), avidinbiotin peroxidase (Vector Laboratories, Burlingame, CA), and subsequently by staining with carbazole (Sigma).
Isolation of mononuclear cells (MNCs) from lymph nodes (LNs) and spleens from rats-
Assays of antigen-induced proliferationAll proliferative experiments were performed in triplicates in 96 well round-bottomed microtiter plates. 2 x 10 5 MNC/well in 100 µl CM were cultured with or without the relevant antigen for 60 h and, subsequently, pulsed with 0.5 mCi ELISA-For detection of the different rHuMOG preparations by 8-18C5, 96-well Maxisorb plates (Nunc, Roskilde, Denmark) were coated overnight at 4°C with serial dilutions of the proteins in 0.1 M NaHCO 3 pH 8.3. Plates were washed with PBS/ 0.05% Tween and blocked for 1 hour at room temperature with 5% BSA in PBS. After washing, wells were incubated for 1 hour with 8-18C5 (2 µg/ ml) in PBS. Plates were washed once more and bound 8-18C5 antibody was detected with a polyclonal sheep-anti-mouse IgG (1/ 10 000 in PBS; Amersham Biosciences, Piscataway, NJ, USA), incubated on the plates for 1 hour at room temperature. After a final washing step, the reaction was visualized with TMB (Sigma). The enzymatic reaction was stopped after 10 minutes by addition of 1 M HCl and the optical density at 450 nm was measured.
For detection of rHuMOG REF IgG antibodies in rat serum, 96-well plates were coated overnight at 4°C with 3 µg/ ml rHuMOG REF in 0.1 M NaHCO 3 pH 8.3. Plates were washed with PBS/ 0.05% Tween and blocked for 1 hour at room temperature with 5% milk powder in PBS. After washing, wells were incubated for 1 hour with rat serum, serially diluted in PBS. Plates were washed and a rabbitanti-rat IgG (1/ 2000 in PBS, Nordic, Tilburg, The Netherlands) was added and incubated for 1 hour at room temperature. Plates were washed prior to the addition of peroxidase-conjugated goat-anti-rabbit antiserum (1/ 10 000 in PBS, Nordic). After 30 minutes of incubation, plates were washed and bound antibodies were visualized by addition of TMB (Sigma). The enzymatic reaction was stopped after 10 minutes by addition of 1 M HCl and the optical density at 450 nm was measured.
Flow cytometric cell sorting-LTK cells transfected with complete human MOG cDNA were a kind gift of Prof. C. Linington (University of Glasgow, United Kingdom). LTK-MOG cells were maintained in complete DMEM with 10% FCS and 1 mg/ ml G418 (Sigma). To detect antibody responses to native MOG, transfected and non-transfected LTK cells were washed with PBS/ 1% BSA/ 0.02% NaN 3 and incubated with rat serum (1/ 500) on ice for 1 hour. Subsequently, cells were stained with biotinylated anti-rat IgG (Sigma) and labelled with streptavidine-PE (Pharmingen, San Diego, CA, USA). Finally, cells were analyzed by FACS (BD Biosciences, San Jose, CA, USA). Negative controls were done with secondary antibody alone.
Data analysis-Statistical analysis was performed using Sigmastat 2.0 Software (Systat, San Jose, CA, USA). The Mann-Whitney Rank Sum test or Students t-test were used for statistical comparisons between different study groups. Data are presented as mean values ± SEM (n.s., not significant, *P<0.05, **P<0.01).
RESULTS
Characterization of rHuMOGrefrHuMOG was expressed in E.coli and preparations of rHuMOG PBS , rHuMOG AC and rHuMOG REF were generated as described in materials and methods. The purified proteins were subjected to SDS-PAGE (Fig. 1) . rHuMOG PBS and rHuMOG AC clearly contain multimeric forms of the proteins, which are probably generated by incorrect pairing of the cysteine residues present in the extracellular MOG domain. In contrast, only monomeric rHuMOG was detected by SDS-PAGE after refolding.
Next (Fig. 3B) .
Antibodies against refolded rHuMOG recognize conformational MOG epitopes-Sera of immunized rats taken at day 20 p.i. were analyzed by ELISA to measure the amount of anti-rHuMOG REF IgG present in the sera and by FACS to identify responses against eukaryotic native MOG protein expressed on the surface of MOG-transfected cells (7, 31 (Fig. 4A) .
In addition, sera were analyzed by FACS to detect the presence of IgG antibodies against native MOG as expressed on the surface of MOG-transfected cells. Contrarily to the results obtained by ELISA, rats immunized with rHuMOG REF raised a significantly higher IgG response against native MOG as rHuMOG PBSimmunized animals (P=0.017) or rHuMOG ACimmunized animals (P<0.001) (Fig. 4B,C) . It was shown previously that FACS-based assays using MOG-transfectants primarily detect antibodies against conformation dependent epitopes, which are probably implicated in antibody dependent demyelination (7 (Fig. 6) .
These results are in complete accordance with the IFN-γ responses measured against the dominant encephalitogenic MOG 91-108 peptide after immunization with the different rHuMOG preparations.
DISCUSSION
The data presented here demonstrate that refolding rHuMOG strongly enhances its encephalitogenicity. Surprisingly, this increase in pathogenic potential could not exclusively be attributed to the enhanced presence of antibodies recognizing the native form of the protein since we found an equally strong increase of the encephalitogenic potential of ensuing T-cell responses after immunization with rHuMOG REF .
Several recent studies in MS and EAE have emphasized the importance of MOG tertiary structure for detection of pathogenic conformational MOG antibodies (8, 11, 34) . We wanted to apply this information in an EAE model and demonstrate an increased pathogenicity of bacterially produced extracellular MOG upon refolding since an increase in the presence of conformational MOG antibodies was to be expected. DA rats readily develop induced autoimmune diseases: immunization of these rats with rRMOG leads to a severe, chronic type of EAE, characterized by demyelination and axonal loss (18, 20) . Despite a high sensitivity to rRMOG induced-EAE, we found that DA rats did not develop EAE after immunization with the equivalent human version of the protein. In this respect, it is interesting to mention that it was previously described that rat and human rMOG induce EAE in C57/BL6 mice by different mechanisms (22) (23) (24) . More specifically, only rHuMOG induced EAE in these mice is B-cell dependent. This B-cell dependency is strictly determined by the presence of a proline at position 42 of the human MOG protein (serine at position 42 of the rat protein). Moreover, it was shown that only immunization with rHuMOG and not rRMOG leads to the generation of a pathogenic antibody response (25) . Still, the biochemical basis for a link between the presence of proline/ serine at position 42 and the generation of a pathogenic antibody response remains to be elucidated. In conclusion, the combination of autoimmune prone DA rats, resistant to disease induction with rHuMOG seemed to us the ideal starting point for studying the potentially enhanced encephalitogenicity of a refolded version of rHuMOG.
Refolding rHuMOG affected both solubility of the protein i.e. it became completely soluble in PBS as well as the affinity of the conformational 8-18C5 antibody for the refolded protein. The MOG-antibody 8-18C5 mediates in vitro and in vivo demyelination and recognizes a discontinuous epitope consisting of three different loops in the extracellular part of the protein (30) . Although 8-18C5 recognizes a conformational MOG epitope, it has been widely used as a positive control in Western-blotting assays (performed under denaturing conditions) for the detection of MOG antibodies. In line with these results, we show that although 8-18C5 has a residual affinity for non-refolded rHuMOG PBS and rHuMOG AC as measured by ELISA, the antibody reacts much stronger with rHuMOG REF .
It has been previously reported that MOG solubility influences EAE severity (19, 26, 35) in such a way that more soluble preparations tend to be more pathogenic. To distinguish effects due to protein solubility from effects due to protein conformation, we decided to include non-refolded rHuMOG solubilized by dialysis against a low-pH acetate buffer in this study. Immunization of DA rats with rHuMOG REF lead to a rapid onset, acute type of EAE which was frequently fatal and was histopathologically characterized by massive inflammation in the presence of sparse demyelination. These results are in line with previous observations showing a similar histopathological pattern in early stages of acutely progressing MOG-induced EAE (19, 35) . The aggregated form of the protein could not induce disease in DA rats whereas the nonrefolded but soluble form of the protein lead to a moderate type of EAE with late onset and with a lower incidence than rHuMOG REF . From these data we conclude that both protein solubility and conformation influence disease outcome and severity.
We could not detect significant differences in anti-MOG-IgG production between different groups as measured by ELISA, irrespective of the rHuMOG preparation which was used for coating the 96-well plates. Although it was previously suggested that even after extensive refolding, recombinant bacterial MOG denatures during ELISA protocols (34), we consistently measured strong reactions of polystyrene-coated rHuMOG REF with the conformational 8-18C5 antibody (36) . An alternative explanation for these results might be offered by the fact that part of the antibody responses in the immunized animals could be raised against trace amounts of host-derived contaminants or against the His-tag and thus are irrelevant for disease.
Alternatively, we measured anti-MOG IgG responses using FACS: this cell-based assay specifically measures antibodies against eukaryotic, conformationally folded, human MOG expressed in the cell-membrane of transfected LTK-cells (7, 31 (37) . In that respect it is interesting to note that non-refolded aggregated rMOG as present in inclusion bodies consists of intermolecular associations of exposed hydrophobic surfaces on folding intermediates resistant to proteolytic degredation (38) and thus might be poorly available for antigen processing which might explain the absent MOG 91-108 T-cell responses after immunization with the aggregated form of the protein.
In conclusion, our results demonstrate that in EAE, the conformation of the rHuMOG protein used for immunization strongly influences the presence of conformational antibodies. Importantly, rHuMOG conformation also has a very strong impact on T-cell immunogenicity. Whether this effect is directly due to protein conformation which might influence APC-uptake and antigen processing or whether altered T-cell immunogenicity is mainly a consequence of protein solubility, remains to be determined. It was previously shown that, at least in the case of MBP, the native protein and the recombinant protein behave antigenically similar as far as B-and T-cell responses are concerned (39) . This is in stark contrast to our findings with MOG. We believe that our results have a wide relevance since the data imply that it is important to use antigens in a form which is similar to the native antigen not only when looking at antibody responses, but even when considering T-cell responses to this (auto)antigen. 
